Vaccination with plasmacytoid dendritic cells induces protection against infection with Leishmania major in mice

European Journal of Immunology

Volumn 37, Issue 9, 2007, Pages 2463-2473

  Remer, Katharina A ^a   Apetrei, Calin ^a   Schwarz, Tobias ^a   Linden, Christian ^a   Moll, Heidrun ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Laishmania major; Plasmacytoid dendritic cells; T helper cell response; Vaccination

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; CD86 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; DENDRITIC CELL VACCINE; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CELL ACTIVATION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; INFECTION RESISTANCE; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; UPREGULATION; VACCINATION;

ANIMALS; ANTIBODIES; APOPTOSIS; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DISEASE SUSCEPTIBILITY; FEMALE; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LYMPH NODES; MICE; MICE, INBRED BALB C; SPLEEN; UP-REGULATION; VACCINATION;

EID: 34548767196     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636780     Document Type: Article

References (55)

1. Sacks, D. and Noben-Trauth, N., The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2002. 2: 845-858.
2. Ramírez-Pineda, J. R., Fröhlich, A., Berberich, C. and Moll, H., Dendritic cells (DC) activated by CpG DNA ex vivo are potent inducers of host resistance to an intracellular pathogen that is independent of IL-12 derived from the immunizing DC. J. Immunol. 2004. 172: 6281-6289.
3. Flohé, S. B., Bauer, C., Flohé, S. and Moll, H., Antigen-pulsed epidermal Langerhans cells protect susceptible mice from infection with the intracellular parasite Leishmania major. Eur. J. Immunol. 1998. 28: 3800-3811.
4. Berberich, C., Ramírez-Pineda, J. R., Hambrecht, C., Alber, G., Skeiky, Y. A. W. and Moll, H., Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens. J. Immunol. 2003. 170: 3171-3179.
5. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
6. Dubsky, P., Ueno, H., Piqueras, B., Connolly, J., Banchereau, J. and Palucka, A. K., Human dendritic cell subsets for vaccination. J. Clin. Immunol. 2005. 25: 551-572.
7. Shortman, K. and Liu, Y. J., Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2002. 2: 151-161.
8. Asselin-Paturel, C., Boonstra, A., Dalod, M., Durand, I, Yessaad, N., Dezutter-Dambuyant, C., Vicari, A. et al., Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2001. 2: 1144-1150.
9. Hemmi, H., Kaisho, T., Takeda, K. and Akira, S., The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 2003. 170: 3059-3064.
10. Iwasaki, A. and Medzhitov, R., Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004. 5: 987-995.
11. Liu, Y. J., IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005. 23: 275-306.
12. McKenna, K, Beignon, A. S. and Bhardwaj, N., Plasmacytoid dendritic cells: Linking innate and adaptive immunity. J. Virol. 2005. 79: 17-27.
13. Krug, A., Veeraswamy, R., Pekosz, A., Kanagawa, O., Unanue, E. R., Colonna, M. and Cella, M., Interferon-producing cells fail to induce proliferation of naïve T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells. J. Exp. Med. 2003. 197: 899-906.
14. Boonstra, A., Asselin-Paturel, C., Gilliet, M., Crain, C., Trinchieri, G., Liu, Y. J. and O'Garra, A., Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: Dependency on antigen dose and differential toll-like receptor ligation. J. Exp. Med. 2003. 197: 101-109.
15. Geijtenbeek, T. B., van Vliet, S. J., Engering, A., 't Hart, B. A. and van Kooyk, Y., Self- and nonself-recognition by C-type lectins on dendritic cells. Annu. Rev. Immunol. 2004. 22: 33-54.
16. Chen, C. H., Floyd, H., Olson, N. E., Magaletti, D., Li, C., Draves, K. and Clark, E. A., Dendritic-cell-associated C-type lectin 2 (DCAL-2) alters dendritic-cell maturation and cytokine production. Blood 2006. 107: 1459-1467
17. Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., Akira, S., Ahmed, R. and Pulendran, B., Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J. Exp. Med. 2006. 203: 413-424.
18. de Jong, E. C., Vieira, P. L., Kalinski, P., Schuitemaker, J. H., Tanaka, Y., Wierenga, E. A., Yazdanbakhsh, M. and Kapsenberg, M. L., Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse T cell-polarizing signals. J. Immunol. 2002. 168: 1704-1709.
19. Manickasingham, S. P., Edwards, A. D., Schulz, O. and Reis e Sousa, C., The ability of murine dendritic cell subsets to direct T helper cell differentiation is dependent on microbial signals. Eur. J. Immunol. 2003. 33: 101-107.
20. Mattner, F., Magram, J., Ferrante, J., Launois, P., Di Padova, K., Behin, R., Gately, M. K. et al., Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 1996. 26: 1553-1559.
21. Wagner, H., Interactions between bacterial CpG-DNA and TLR9 bridge innate and adaptive immunity. Curr. Opin. Microbiol. 2002. 5: 62-69.
22. Krug, A., Rothenfusser, S., Hornung, V., Jahrsdörfer, B., Blackwell, S., Ballas, Z. K, Endres, S. et al., Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells. Eur. J. Immunol. 2001. 31: 2154-2163.
23. Okada, T., Lian, Z. X., Naiki, M., Ansari, A. A., Ikehara, S. and Gershwin, M. E., Murine thymic plasmacytoid dendritic cells. Eur. J. Immunol. 2003. 33: 1012-1019.
24. + dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential. Blood 2002. 100: 383-390.
25. + regulatory T cells. J. Immunol. 2004. 173: 4433-4442.
26. + T-cell responses in vivo after viral stimulation. Blood 2004. 104: 1808-1815.
27. Ji, J., Sun, J., Qi H. and Soong, L., Analysis of T helper cell responses during infection with Leishmania amazonensis. Am. J. Trop. Med. Hyg. 2002. 66: 338-345.
28. Mazumdar, T., Anam, K. and Ali, N., A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice. Vaccine 2004. 22: 1162-1171.
29. Basu, R., Bhaumik, S., Basu, J. M., Naskar K., De, T. and Roy, S., Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: Evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. J. Immunol. 2005. 174: 7160-7171.
30. Ghosh, A., Zhang, W. W. and Matlashewski, G., immunization with A2 protein results in a mixed Th1/Th2 and a humoral response which protects mice against Leishmania donovani infections. Vaccine 2001. 20: 59-66.
31. Streit, J. A., Recker, T. J., Filho, F. G., Beverley, S. M. and Wilson, M. E., Protective immunity against the protozoan Leishmania chagasi is induced by subdinical cutaneous infection with virulent but not avirulent organisms. J. Immunol. 2001. 166: 1921-1929.
32. Lamb, T. J., Graham A. L., Le Groff, L. and Allen, J. E., Co-infected C57BL/6 mice mount appropriately polarized and compartmentalized cytokine responses to Litomosoides sigmodontis and Leishmania major but disease progression is altered. Parasite Immunol. 2005. 27: 317-324.
33. Kamogawa, Y., Minasi, L. A., Carding, S. R., Bottomly, K. and Flavell, R. A., The relationship of IL-4- and IFN-γ-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 1993. 75: 985-995.
34. Schüler, T., Qin, Z., Ibe, S., Noben-Trauth, N. and Blankenstein, T. T. helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice. J. Exp. Med. 1999. 189: 803-810.
35. Satoskar, A., Bluethmann, H. and Alexander, J., Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection. Infect. Immun. 1995. 63: 4894-4899.
36. Bullens, D. M., Kasran, A., Thielemans, K., Bakkus, M. and Ceuppens, J. L., CD40L-induced IL-12 production is further enhanced by the Th2 cytokines IL-4 and IL-13. Scand. J. Immunol. 2001. 53: 455-463.
37. Biedermann, T., Zimmermann, S., Himmelrich, H., Gumy, A., Egeter, O., Sakrauski, A. K., Seegmüller, I. et al., IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat. Immunol. 2001. 2: 1054-1060.
38. Gicheru, M. M., Olobo, J. O., Anjili, C. O., Orago, A. S., Modabber, F. and Scott, P., Vervet monkeys vaccinated with killed Leishmania major parasites and interleukin-12 develop a type 1 immune response but are not protected against challenge infection. Infect. Immun. 2001. 69: 245-251.
39. Sjölander, A., Baldwin, T. M., Curtis, J. M., Bengtsson, K. L. and Handman, E., Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection. Vaccine 1998. 16: 2077-2084.
40. Ferlazzo, G. and Münz, C., NK cell compartments and their activation by dendritic cells. J. Immunol. 2004. 172: 1333-1339.
41. hi T regulatory cells. Eur. J. Immunol. 2005. 35: 2452-2458.
42. Münz, C., Steinman, R. M. and Fujii, S., Dendritic cell maturation by innate lymphocytes: Coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 2005. 202: 203-207.
43. Bogdan, C., Stenger, S., Röllinghoff, M. and Solbach, W., Cytokine interactions in experimental cutaneous leishmaniasis. Interleukin 4 synergizes with interferon-γ to activate murine macrophages for killing of Leishmania major amastigotes. Eur. J. Immunol. 1991. 21: 327-333.
44. de Veer, M. J., Curtis, J. M., Baldwin, T. M., DiDonato, J. A., Sexton, A., McConville, M. J., Handman, E. and Schofield, L., MyD88 is essential for clearance of Leishmania major: Possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur. J. Immunol. 2003. 33: 2822-2831.
45. Becker, I., Salaiza, N., Aguirre, M., Delgado, J., Carrillo-Carrasco, N., Gutiérrez Kobeh, L., Ruiz, A. et al., Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol. Biochem. Parasitol. 2003. 130: 65-74
46. Kropf, P., Freudenberg, N., Kalis, C., Modolell, M., Herath, S., Galanos, C., Freudenberg, M. and Müller, I., Infection of C57BL/ 10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication. J. Leukoc. Biol. 2004. 76: 48-57
47. Brawand, P., Fitzpatrick D. R., Greenfield, B. W., Brasel, K., Maliszewski, C. R. and De Smedt, T., Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J. Immunol. 2002. 169: 6711-6719.
48. Miller, G., Pillarisetty, V. G., Shah, A. B., Lahrs, S. and DeMatteo, R. P., Murine FIt3 ligand expands distinct dendritic cells with both tolerogenic and immunogenic properties. J. Immunol. 2003. 170: 3554-3564.
49. Cameron, P., MeGachy, A., Anderson, M., Paul, A., Coombs, G. H., Mottram, J. C., Alexander, J. and Plevin, R., Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: The role of cysteine peptidases and the NF-κB signaling pathway. J. Immunol. 2004. 173: 3297-3304.
50. Belkaid, Y., Butcher, B. and Sacks, D. L., Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: selective impairment of IL-12 induction in Leishmania-infected cells. Eur. J. Immunol. 1998. 28: 1389-1400.
51. Carrera, L., Gazzinelli, R. T., Badolato, R., Hieny, S., Müller, W., Kühn, R. and Sacks, D. L., Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 1996. 183: 515-526.
52. van Kooyk, Y., Engering, A., Lekkerkerker, A. N., Ludwig, I. S. and Geijtenbeek, T. B., Pathogens use carbohydrates to escape immunity induced by dendritic cells. Curr. Opin. Immunol. 2004. 16: 488-493.
53. Bosnjak, I., Miranda-Saksena, M., Koelle, D. M., Boadle, R. A., Jones, C. A. and Cunningham, A. L., Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J. Immunol. 2005. 174: 2220-2227.
54. Lutz, M. B., Kukutsch, N., Ogilvie, A. L., R_̈bsoner, S., Koch, F., Romani, N. and Schuler, G., An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 1999. 223: 77-92.
55. Lima, H. C., Bleyenberg, J. A. and Titus, R. G., A simple method for quantifying Leishmania in tissues of infected animals. Parasitol. Today 1997. 13: 80-82.